Moderna (MRNA) Stock Slips Despite Beating Q4 Revenue and Earnings Estimates - Blockonomi

Moderna reported Q4 revenue of $678 million, beating Wall Street estimates of $626.1 million, driven by COVID-19 vaccine sales • The company posted a quarterly loss of $2.11 per share, narrower than t... [2998 symbols]

Últimos artigos